Arnab Chakravarti

Evolution of Gliomas During Treatment and Resistance

National Cancer Institute · R01

PI · $3.5M · Dana-Farber Cancer Inst

OSU as a Network Lead Academic Participating Site for the NCI NCTN

National Cancer Institute · UG1

PI · $7.8M · Ohio State University

Defining the Molecular Mechanisms Regulating the Hexosamine-N-Glycosylation Pathway in Glioblastoma

National Cancer Institute · R01

PI · $1.5M · Ohio State University

Novel Functions of Pyruvate Kinase M2 in DNA Double-Strand Break Repair

National Cancer Institute · R01

PI · $2M · Univ of Arkansas for Med Scis

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Principal investigator · Active not recruiting · Phase 2

Ohio State University

Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Principal investigator · Terminated · Phase 2

Ohio State University

Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy

Principal investigator · Completed

Ohio State University Comprehensive Cancer Center

Changes in DNA After Radiation Therapy in Patients With Prostate Cancer

Study chair · Completed

Radiation Therapy Oncology Group